LXRX Shares Outstanding History



Below is a table of the LXRX shares outstanding history going back to 5/21/2015:

Date LXRX Shares Outstanding
5/21/20150.10B
8/4/2015103.61M
11/4/2015103.62M
3/7/2016103.77M
5/2/2016103.82M
6/13/2016103.85M
8/1/2016103.87M
11/3/2016104.04M
3/1/2017104.32M
5/1/2017105.24M
7/28/2017105.58M
11/6/2017105.59M
2/26/2018105.59M
4/30/2018105.83M
7/26/2018105.88M
10/29/2018105.93M
3/8/2019106.27M
4/29/2019106.27M
7/29/2019106.27M
11/4/2019106.27M
3/6/2020106.97M
4/23/2020106.97M
7/24/2020107.11M
10/26/2020117.47M
5/4/2021144.39M
8/3/2021144.47M
11/1/2021148.90M
3/8/2022149.59M
5/4/2022149.59M
8/3/2022183.63M
11/7/2022188.73M
3/1/2023188.73M
8/1/2023244.92M
11/6/2023244.92M
3/21/2024246.24M

Also see: LXRX Market Cap History
LXRX YTD Return
LXRX Historical Shares Outstanding:
+10.29% CAGR
LXRX Historical Shares Outstanding: +10.29% CAGR

Mouse over chart for data details
5/21/2015 ...3/21/2024
Lexicon Pharmaceuticals is a biopharmaceutical company. Co. discovers the functions and pharmaceutical utility of genes and uses those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. Co. is also developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Co. is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain. In addition, Co. is conducting preclinical research and development and preparing to conduct clinical development of compounds from several additional drug programs. We show 35 historical shares outstanding datapoints in our coverage of LXRX's shares outstanding history.

Understanding the changing numbers of LXRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LXRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LXRX by allowing them to research LXRX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree LXRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Lexicon Pharmaceuticals (LXRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

LYEL Shares Outstanding History
LYRA Shares Outstanding History
MACK Shares Outstanding History
MASI Shares Outstanding History
MBIO Shares Outstanding History
MBOT Shares Outstanding History
MBRX Shares Outstanding History
MBVX Shares Outstanding History
MCK Shares Outstanding History
MCRB Shares Outstanding History
More Healthcare companies »

 

LXRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.